does insurance pay for glp-1 The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Will Insurance Cover My GLP-1

Back Current Obesity Report, 12/2, 61-74

But I believe Its even a more of a impetus for pharma companies to rethink their pricing methodology, which is the removal of the cap for the average manufacturer price for Medicaid rebates

Amplitude O (Effect of Efpeglenatide on Cardiovascular Outcomes) revealed that patients with type 2 DM and CVD or kidney disease receiving once weekly efpeglenatide had a 27% lower incidence of the primary composite outcome and 32% lower risk of a composite renal outcome event compared to those receiving placebo [17]

The absolute reduction in LFC at week 52 was significantly greater for the tirzepatide 10 mg and 15 mg group versus the insulin degludec group